Nearly 1 in 4 people with pancreatic cancer are also diagnosed with diabetes. Dr. Suresh Chari of @MDAndersonnews joins Alisyn Camerota to explain the diabetes–pancreatic cancer connection, symptoms to watch for, and the latest early detection research. https://t.co/a9w1ZQs34o
Clinical psychologist Stephanie Davidson provides caregivers and patients with techniques to master difficult conversations during treatment. https://t.co/bRqre6zEmh
When a loved one is being treated for pancreatic cancer, caregivers become at-home nurses. Marci Andrejko provides some best practices. https://t.co/roySrBVeJc
Hear 🎧 what you've been missing on the PancChat #PancreaticCancer Podcast with host @AlisynCamerota. PancChat is a collaboration between Let's Win and @PanCAN. https://t.co/XH4HF3FdeL
Did you miss the #PancChat Episode with @TheVinodLab on #PancreaticCancer Vaccines? Watch or listen: https://t.co/gTVe8CF1TC
PancChat is a collaboration between Let's Win and @PanCAN. 💜
Members of the Patient Advisory Board discuss the changes they would like to see in 10 years in treatment, early detection, and managing care. https://t.co/hxbjQjHIa0
In the heat of the summer, pancreatic cancer patients face summer safety challenges so they don’t overheat, burn, or exhaust themselves. https://t.co/TZCiz7k1Dn
How a low protein diet improves the immune response to pancreatic cancer, reshaping the gut microbiome, in the experimental model and patients
https://t.co/0MYwzfMsqf
🆕📝Pharmacokinetics ➕Pharmacodynamics of
🟢Localized intra-arterial Gemcitabine⬆️⬆️
Advantages:
⬆️increased tissue concentration
⬇️decreased systemic dosing/toxicity
More pertinent in an era of better systemic
#PANCSM@OncoAlert#KRAS@PanCAN
🔗 https://t.co/xygYBkwTI3
Katie DeCarlo is continuously fighting her PNET. She is determined to try and will continue to try as many types of treatment as possible. https://t.co/rcwquBlywz
Important work from the @HopkinsMedicine#PancreaticCancer high-risk cohort surveillance team: Dr. Mimi Canto and the team at Johns Hopkins have identified a dilated pancreatic duct as a risk factor for pancreatic cancer. https://t.co/QDHYxWzQpY
Daraxonrasib is a game changer for metastatic pancreatic cancer — but it comes with side effects, including a skin rash. Dr. Ian Tattersall explains what to expect and how to prepare.
🔗 Link to read the full article: https://t.co/tjGMhGJVJt
Nearly 1 in 4 people with pancreatic cancer are also diagnosed with diabetes. Dr. Suresh Chari of @MDAndersonnews joins Alisyn Camerota to explain the diabetes–pancreatic cancer connection, symptoms to watch for, and the latest early detection research. https://t.co/a9w1ZQs34o
On PancChat, Dr.Suresh Chari explains why sudden blood sugar spikes+unexpected weight loss can be a key early warning sign & how AI-assisted imaging is working to spot tumors. https://t.co/akiCx3aeSj
@PanCAN@letswinpc
Could a sudden change in blood sugar be an early sign of pancreatic cancer? Dr. Suresh Chari explains the diabetes connection in this episode of PancChat. https://t.co/sCTk0cQPY6
Could a widened pancreatic duct be an early warning sign of pancreatic cancer? New research from Johns Hopkins suggests that in high-risk individuals, even mild pancreatic duct dilation, with no visible mass, shouldn’t be overlooked. https://t.co/QDHYxWzQpY
@asullivan1124 It is. And are have an entire section on this, where you will also find info on screening programs https://t.co/dP6lfuNZD0 Agree on worst disease ever. 💜